Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury (2014)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/2045-7022-4-s3-o3
Publication URI: http://dx.doi.org/10.1186/2045-7022-4-s3-o3
Type: Journal Article/Review
Parent Publication: Clinical and Translational Allergy
Issue: S3